Interaction-constrained 3D molecular generation using a diffusion model enables structure-based pharmacophore modeling for drug design

16 June 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A key challenge in structure-based drug design is generating three-dimensional molecules while preserving essential protein–ligand interactions. We propose a structure-based pharmacophore modeling framework based on a conditional diffusion model to generate molecules that satisfy specified interaction constraints. The proposed method incorporates a semantic fusion architecture that integrates multiple interaction-specific neural networks, each designed to capture distinct molecular interactions such as hydrogen bonds and hydrophobic interactions. The effectiveness of the method is demonstrated through a practical case study targeting the SARS-CoV-2 main protease, a critical antiviral target. Molecular dynamics simulations reveal that the generated molecules maintain both structural stability and key interactions comparable to those of a bioactive reference ligand. Binding free energy calculations using the molecular mechanics generalized Born surface area (MM/GBSA) method further demonstrate that several generated molecules exhibit more favorable binding affinities than that of the reference. ADMET profiling indicates that the generated molecules possess desirable drug-likeness and pharmacokinetic properties. The method also demonstrates generalizability to other protein targets and generates synthetically accessible molecules.

Keywords

drug discovery
Diffusion model
pharmacophore
SBDD

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.